Economy

Sophiris Bio, Inc. (NASDAQ:SPHS) Experiences Light Trading Volume

More interesting news about Sophiris Bio Inc (NASDAQ:SPHS) were released by: Prnewswire.com and their article: "Sophiris Bio To Present Topsalysin Phase 3 Data from Positive PLUS-1 Study as ..." published on May 05, 2016 as well as Prnewswire.com's news article titled: "Sophiris Bio to Present at 29th Annual ROTH Conference" with publication date: March 06, 2017.

11/11/2015 - Street Watchdog Research began new coverage on Sophiris Bio, Inc. giving the company a "buy" rating. One of the most popular ratios is the "Return on Assets" (aka ROA).

The Value Composite One (VC1) is a method that investors use to determine a company's value.

C M Bidwell & Associates Ltd. reduced its position in shares of Bio-Rad Laboratories, Inc. (NasdaqCM:SPHS) is 87. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The value of the investment in Sophiris Bio, Inc. increased from $149,000 to $787,000 a change of 428.2% quarter to quarter. (NasdaqCM:SPHS) is 91.

Sophiris Bio, Inc., formerly Protox Therapeutics Inc., is a Canada biopharmaceutical firm focused on the research, development and commercialization of products for the treatment of urological diseases. This indicator was developed by James Montier in an attempt to identify firms that were altering financial numbers in order to appear better on paper. (NYSE:BIO) is 4. A score of nine indicates a high value stock, while a score of one indicates a low value stock. If the score is -1, then there is not enough information to determine the C-Score. Montier used six inputs in the calculation. The value of the total investment in Sophiris Bio, Inc. decreased from $71,000 to $61,000 a change of $10,000 for the reporting period. Following the completion of the sale, the executive vice president now directly owns 2,060 shares in the company, valued at $444,774.60. Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. Jpmorgan Chase & Co reported 0% of its portfolio in Sophiris Bio Inc (NASDAQ:SPHS). The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, "The Little Book that Beats the Market". Value is a helpful tool in determining if a company is undervalued or not. The price index of Bio-Rad Laboratories, Inc. TheStreet cut shares of Bio-Rad Laboratories from a b rating to a c+ rating in a report on Thursday, August 3rd. Deutsche Bank AG restated a buy rating and issued a $255.00 target price on shares of Bio-Rad Laboratories in a report on Monday, September 18th. The average FCF of a company is determined by looking at the cash generated by operations of the company. Sophiris Bio, Inc. has a 52-week low of 1.80 and a 52-week high of 3.30.

We see here that the stock is 5.66% away from the 20-Day Simple Moving Average.

TRADEMARK VIOLATION NOTICE: "Bio-Rad Laboratories, Inc". (NYSE:BIO) is 22.787400. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 43.2157. Also, the number of institutional investors holding Sophiris Bio Inc in their top 10 equity positions was flat from 0 to 0 for the same number. This is calculated by taking the current share price and dividing by the share price one month ago. A ratio over one indicates an increase in share price over the period. If the ratio is less than 1, then we can determine that there has been a decrease in price. Looking at some alternate time periods, the 12 month price index is 0.95082, the 24 month is 0.12826, and the 36 month is 0.14500. Narrowing in a bit closer, the 5 month price index is 0.82335, the 3 month is 0.93833, and the 1 month is now 0.92609. The stock has a market cap of $6.71 billion, a price-to-earnings ratio of 447.15 and a beta of 0.91. ROIC helps show how efficient a firm is at turning capital into profits. Checking in on some other ratios, the company has a Price to Cash Flow ratio of 43.286693, and a current Price to Earnings ratio of 433.138842. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. The Piotroski F-Score of bluebird bio, Inc.

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value.



Like this

Latest


07 October 2017
Foo Fighters say their Carpool Karaoke experience was 'a little uncomfortable'
Before Linkin Park's lead singer Chester Bennington died earlier this year, the band recorded an episode Carpool Karaoke . Smear agreed that "singing other people's songs would have been easier". "I don't know why".

07 October 2017
Netflix is Increasing Monthly Subscription Prices
The top-tier plan, which allows streaming on four screens in high definition, was raised to $13.99 per month from $11.99. Many Netflix subscribers across the United States are going to be a little lighter in the wallet starting next month.

07 October 2017
Hartford Financial Services Gro (NYSE:HIG) Experiences Lighter than Average Trading Volume
The value of the investment in ( HIG ) decreased from $11,889,000 to $6,875,000 a change of 42.2% for the reporting period. The insurance provider reported $1.04 EPS for the quarter, topping the Zacks' consensus estimate of $0.94 by $0.10.

07 October 2017
Maduro arribó a Turquía para fortalecer acuerdos bilaterales
Luego asistió a la Universidad de Ankara , de la cual recibió un título Honoris Causa por "la amistad eterna" entre ambos países .

07 October 2017
4th Fort Bragg-based solider killed in Niger is identified
There are about 800 US military personnel in Niger helping that country's counterterrorism efforts against extremist groups. Eight Niger soldiers and two USA soldiers were wounded, according to a statement by Niger's Army Chief of Staff.

07 October 2017
Virtu KCG Holdings LLC Takes Position in Herbalife LTD. (HLF)
The company reported $1.51 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.10 by $0.41. Zacks Investment Research downgraded Herbalife LTD. from a strong-buy rating to a hold rating in a report on Tuesday, July 4th.

07 October 2017
How Jason Taumalolo handled it was disappointing - Kiwis selector Tony Iro
Echoing Johnson's comment about playing with "this group of men", Blair said Taumalolo wasn't man enough to confront Kidwell about his decision.

07 October 2017
Russia Signs $3 Billion Arms Deal With Saudi Arabia
A separate $10 billion joint investment fund would support Russian projects in various sectors. The king may also seek assurances that Iran will not have a permanent role in Syria.

07 October 2017
God Eater: Resonant Ops announced for smartphones
Along with his or her allies, the protagonist, a rookie God Eater , will throw himself or herself into battle in restricted areas. It's expected that God Eater 3 will be released worldwide, including the Americas, Europe, Japan, and Southeast Asia.

07 October 2017
Oil Rises With New OPEC Deal
Last week's figure also beat the previous record set by exporters, which was hit in the previous week, at 1.5 million bpd. The global benchmark crude traded at a premium of $5.48 to December WTI.



Recommended